Please check your internet connection and try again.
# Walethmade Bromide
## Overview
Walethmade bromide is a synthetic opioid agonist with a chemical structure similar to methadone. It is primarily used for its analgesic properties.
## Primary Indications
* Moderate to severe pain management.
## Adult Dosing
The appropriate dose of walethmade bromide for pain management is highly individualized and depends on the severity of pain, previous opioid exposure, and patient response. A typical starting dose might range from 5-10 mg orally every 6-8 hours as needed for breakthrough pain, or a scheduled dose of 10-20 mg orally every 8-12 hours for chronic pain. **Titration is essential.**
## Pediatric Dosing
Dosing for pediatric patients is not well-established and should be approached with extreme caution. If used, doses should be initiated at the lowest effective dose and carefully titrated under close medical supervision, likely by weight-based calculations with significant downward adjustments compared to adult starting doses.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution. Dose reduction may be necessary.
* **Renal Impairment:** Use with caution. Dose reduction may be necessary, particularly in severe impairment.
## Contraindications
* Known hypersensitivity to walethmade bromide.
* Significant respiratory depression.
* Acute or severe bronchial asthma or hypercapnia.
* Concurrent use with MAO inhibitors or within 14 days of their discontinuation.
## Adverse Effects
Common adverse effects include: constipation, nausea, vomiting, drowsiness, dizziness, sedation, pruritus, and dry mouth.
Serious adverse effects include: respiratory depression, opioid-induced constipation, hypotension, bradycardia, seizures, and potential for dependence and addiction.
## Key Drug Interactions
* **CNS Depressants:** Increased risk of sedation, respiratory depression, coma, and death (e.g., benzodiazepines, alcohol, other opioids, sedatives, hypnotics).
* **MAO Inhibitors:** Potentially life-threatening interactions; avoid concurrent use.
* **CYP3A4 Inhibitors/Inducers:** May alter walethmade bromide plasma concentrations.
## Monitoring
* Pain assessment.
* Respiratory rate, depth, and pattern.
* Sedation level.
* Bowel function.
* Signs of opioid withdrawal.
* Hepatic and renal function as clinically indicated.
## Clinical Pearls
* Walethmade bromide is a potent opioid; start low and titrate slowly.
* Consider naloxone readily available for emergency reversal of opioid-induced respiratory depression.
* Educate patients on the risks of dependence, addiction, and respiratory depression.
* Constipation prophylaxis is crucial for patients on chronic therapy.
***
*This information is intended for clinical use and does not replace a thorough review of the most current prescribing information and relevant literature. Always verify current drug information, especially regarding dosing and safety, with the official product insert or a reputable drug information resource.*
